Literature DB >> 1847695

High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease.

M W Steward1, C M Stanley, R Dimarchi, G Mulcahy, T R Doel.   

Abstract

Previous work has shown that the synthetic peptide C-C-(200-213)-P-P-S-(141-158)-P-C-G, in which residues 200-213 and 141-158 correspond to immunogenic regions of the VP1 protein of foot-and-mouth disease virus (FMDV), is capable of inducing high levels of neutralizing antibody but only inconsistent protection of cattle against virulent FMDV challenge. The possibility exists that differences in affinity may well underlie the observed variations in biological effectiveness of the anti-peptide antibodies in immunized animals. This has been investigated by assessing the affinity for peptide and whole virus of the anti-peptide antibodies in sera from protected and non-protected cattle using both fluid-phase and solid-phase assays. The results obtained show that the affinities of serum antibodies for peptide and virus in protected cattle were significantly higher than those in non-protected animals. Thus in order to assess vaccine efficacy, particularly in the case where synthetic immunogens are employed, consideration should be given to the determination of antibody affinity in addition to other parameters of the antibody response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847695      PMCID: PMC1384343     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Antibody affinity maturation: the role of CD8+ cells.

Authors:  G P Holland; M W Steward
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

3.  Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination.

Authors:  E Beck; K Strohmaier
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines.

Authors:  T W Pay; P J Hingley
Journal:  Vaccine       Date:  1987-03       Impact factor: 3.641

5.  Protection of cattle against foot-and-mouth disease by a synthetic peptide.

Authors:  R DiMarchi; G Brooke; C Gale; V Cracknell; T Doel; N Mowat
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

6.  Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence.

Authors:  J L Bittle; R A Houghten; H Alexander; T M Shinnick; J G Sutcliffe; R A Lerner; D J Rowlands; F Brown
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

7.  Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease.

Authors:  S M Golding; R S Hedger; P Talbot
Journal:  Res Vet Sci       Date:  1976-03       Impact factor: 2.534

8.  Qualitative and quantitative differences in the immune response to foot-and-mouth disease virus antigens and synthetic peptides.

Authors:  M J Francis; C M Fry; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

9.  Synthesis of the antibacterial peptide cecropin A (1-33).

Authors:  R B Merrifield; L D Vizioli; H G Boman
Journal:  Biochemistry       Date:  1982-09-28       Impact factor: 3.162

10.  Thermal stability of foot-and-mouth disease virus.

Authors:  T R Doel; P J Baccarini
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

View more
  12 in total

1.  Synthetic peptides from a conserved region of gp120 induce broadly reactive anti-HIV responses.

Authors:  W J Morrow; W M Williams; A S Whalley; T Ryskamp; R Newman; C Y Kang; S Chamat; H Köhler; T Kieber-Emmons
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

2.  Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.

Authors:  P R Grigera; M Garcia-Briones; O Periolo; J L la Torre; R R Wagner
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine.

Authors:  P Mazzetti; S Giannecchini; D Del Mauro; D Matteucci; P Portincasa; A Merico; C Chezzi; M Bendinelli
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 4.  Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

5.  The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.

Authors:  D Chargelegue; C M Stanley; C M O'Toole; B T Colvin; M W Steward
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

6.  A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.

Authors:  D Chargelegue; C M O'Toole; B T Colvin
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

7.  Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein.

Authors:  Z X Zhang; M Chen; K Wallhagen; J Trojnar; L O Magnius; B Wahren; M Sällberg
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

8.  Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.

Authors:  O E Obeid; C D Partidos; C R Howard; M W Steward
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

9.  A mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response.

Authors:  M W Steward; C M Stanley; O E Obeid
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  On the meaning of affinity limits in B-cell epitope prediction for antipeptide antibody-mediated immunity.

Authors:  Salvador Eugenio C Caoili
Journal:  Adv Bioinformatics       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.